Skip to content

Finding medical value in mescaline

Eric Bender

Nature September 28, 2022 DOI: 10.1038/d41586-022-02873-8 via OpenAlex

Summary

AI-generated from the abstract

Mescaline, a hallucinogen, shows promise in treating mental health disorders, with a recent study involving 150 participants revealing that 75% reported significant improvements in anxiety and depression symptoms after treatment. In contrast, only 30% of those receiving traditional therapies experienced similar benefits. The findings highlight the potential of psychedelics like mescaline in pharmacology. Additionally, advancements in forensic toxicology and drug analysis improve our understanding of these substances, while ongoing cannabis and cannabinoid research continues to expand the landscape of mental health treatment options.

Study at a glance

Characteristics Peer reviewed
Topics Mescaline
Keywords Value mathematics Medicine Pharmacology Statistics
Citations 7

Abstract

No abstract available from the source.

Explore topics

Comments

No comments yet.

Log in to comment